These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21156098)

  • 81. Two-dose vaccination program shows positive impact on varicella incidence.
    Riedmann EM
    Hum Vaccin Immunother; 2013 Dec; 9(12):2500. PubMed ID: 24716205
    [No Abstract]   [Full Text] [Related]  

  • 82. Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program.
    Quinn HE; Gidding HF; Marshall HS; Booy R; Elliott EJ; Richmond P; Crawford N; McIntyre PB; Macartney KK;
    J Infect; 2019 Mar; 78(3):220-225. PubMed ID: 30528868
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Case-control study on the relationship between varicella vaccine inoculation and varicella morbidity].
    Cai JF; Luo FJ; Li JH
    Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):330-2. PubMed ID: 20077732
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Epidemiology of varicella in Haidian district, Beijing, China-2007-2015.
    Fu J; Jiang C; Wang J; Zhao F; Ma T; Shi R; Zhao Y; Zhang X
    Vaccine; 2017 Apr; 35(18):2365-2371. PubMed ID: 28343770
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The impact of ten years of infant universal Varicella vaccination in Sicily, Italy (2003-2012).
    Amodio E; Tramuto F; Cracchiolo M; Sciuto V; De Donno A; Guido M; Rota MC; Gabutti G; Vitale F
    Hum Vaccin Immunother; 2015; 11(1):236-9. PubMed ID: 25483542
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The economic value of childhood varicella vaccination in France and Germany.
    Coudeville L; Brunot A; Szucs TD; Dervaux B
    Value Health; 2005; 8(3):209-22. PubMed ID: 15877593
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Impact and effectiveness of childhood varicella vaccine program in Queensland, Australia.
    Sheridan SL; Quinn HE; Hull BP; Ware RS; Grimwood K; Lambert SB
    Vaccine; 2017 Jun; 35(27):3490-3497. PubMed ID: 28528765
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center.
    Izurieta HS; Strebel PM; Blake PA
    JAMA; 1997 Nov; 278(18):1495-9. PubMed ID: 9363968
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Varicella outbreak in a village in Uruguay].
    Quian R J; Protasio P A; Dall'orso V P; Mas G M; Romero O C; Ferreira J N; Coria R I
    Rev Chilena Infectol; 2010 Feb; 27(1):47-51. PubMed ID: 20140315
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Varicella: epidemiological aspects and vaccination coverage in the Veneto Region.
    Baldo V; Baldovin T; Russo F; Busana MC; Piovesan C; Bordignon G; Giliberti A; Trivello R
    BMC Infect Dis; 2009 Sep; 9():150. PubMed ID: 19737419
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Chickenpox immunisation in New Zealand.
    Tobias M; Reid S; Lennon D; Meech R; Teele DW
    N Z Med J; 1998 Jul; 111(1070):274-81. PubMed ID: 9734530
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Validation of health economic models: the example of EVITA.
    Hammerschmidt T; Goertz A; Wagenpfeil S; Neiss A; Wutzler P; Banz K
    Value Health; 2003; 6(5):551-9. PubMed ID: 14627061
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Is it necessary to vaccinate against varicella?].
    Lepage P; Blumental S
    Rev Med Brux; 2014 Sep; 35(4):335-7. PubMed ID: 25675640
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Study on epidemiological effect of the freeze-dried attenuated live varicella vaccine].
    Ma FB; Luo LY; Zhang LH
    Zhongguo Yi Miao He Mian Yi; 2009 Jun; 15(3):193-5. PubMed ID: 20084878
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Varicella. Universal immunization or selective?].
    Navarro Alonso JA
    Aten Primaria; 1998 Oct; 22(7):457-64. PubMed ID: 9842085
    [No Abstract]   [Full Text] [Related]  

  • 96. Waning Effectiveness of One-dose Universal Varicella Vaccination in Korea, 2011-2018: a Propensity Score Matched National Population Cohort.
    Hong K; Sohn S; Choe YJ; Rhie K; Lee JK; Han MS; Chun BC; Choi EH
    J Korean Med Sci; 2021 Sep; 36(36):e222. PubMed ID: 34519184
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Varicella Vaccination Coverage and Possible Factors Influencing Parental Vaccination Decisions in Munich Area 2009-2011 after Introduction of Routine Varicella Vaccination].
    Hagemann C; Seeger K; Krämer A; Liese JG; Streng A
    Gesundheitswesen; 2017 Apr; 79(4):286-295. PubMed ID: 27077319
    [No Abstract]   [Full Text] [Related]  

  • 98. How cost effective is universal varicella vaccination in developing countries? A case-study from Colombia.
    Paternina-Caicedo A; De la Hoz-Restrepo F; Gamboa-Garay O; Castañeda-Orjuela C; Velandia-González M; Alvis-Guzmán N
    Vaccine; 2013 Jan; 31(2):402-9. PubMed ID: 23174195
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005.
    Quian J; Rüttimann R; Romero C; Dall'Orso P; Cerisola A; Breuer T; Greenberg M; Verstraeten T
    Arch Dis Child; 2008 Oct; 93(10):845-50. PubMed ID: 18456699
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Decline of Neurologic Varicella Complications in Children During the First Seven Years After Introduction of Universal Varicella Vaccination in Germany, 2005-2011.
    Streng A; Grote V; Rack-Hoch A; Liese JG
    Pediatr Infect Dis J; 2017 Jan; 36(1):79-86. PubMed ID: 27749651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.